Starting Material for Autologous Cell Therapies: Beginning with the End in Mind
Time: 1:30 pm
day: Conference Day One
Details:
- Ensuring patient centric process development: moving from healthy donors to patient material
- Exploring monocyte depletion and/or T cell enrichment to manage the heterogeneity of the starting material
- Selecting a cell population that ensures downstream process robustness
